{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:02:38Z","timestamp":1793833358562,"version":"4.6.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>\n                    Parkinson\u2019s disease (PD) and dementia with Lewy body (DLB) are the most common synucleinopathies.\n                    <jats:italic>SNCA<\/jats:italic>\n                    gene is a major genetic risk factor for these diseases group, and dysregulation of its expression has been implicated in the genetic etiologies of several synucleinopathies. DNA methylation at CpG island (CGI) within\n                    <jats:italic>SNCA<\/jats:italic>\n                    intron 1 has been suggested as a regulatory mechanism of\n                    <jats:italic>SNCA<\/jats:italic>\n                    expression, and changes in methylation levels at this region were associated with PD and DLB. However, the role of DNA methylation in the regulation of\n                    <jats:italic>SNCA<\/jats:italic>\n                    expression in a cell-type specific manner and its contribution to the pathogenesis of PD and DLB remain poorly understood, and the data are conflicting. Here, we employed a bisulfite pyrosequencing technique to profile the DNA methylation across\n                    <jats:italic>SNCA<\/jats:italic>\n                    intron 1 CGI in PD and DLB compared to age- and sex-matched normal control subjects. We analyzed homogenates of bulk\n                    <jats:italic>post-mortem<\/jats:italic>\n                    frozen frontal cortex samples and a subset of neuronal and glia nuclei sorted by the fluorescence-activated nuclei sorting (FANS) method. Bulk brain tissues showed no significant difference in the overall DNA methylation across\n                    <jats:italic>SNCA<\/jats:italic>\n                    intron 1 CGI region between the neuropathological groups. Sorted neuronal nuclei from PD frontal cortex showed significant lower levels of DNA methylation at this region compared to normal controls, but no differences between DLB and control, while sorted glia nuclei exhibited trends of decreased overall DNA methylation in DLB only. In conclusion, our data suggested disease-dependent cell-type specific differential DNA methylation within\n                    <jats:italic>SNCA<\/jats:italic>\n                    intron 1 CGI. These changes may affect\n                    <jats:italic>SNCA<\/jats:italic>\n                    dysregulation that presumably mediates disease-specific risk. Our results can be translated into the development of the\n                    <jats:italic>SNCA<\/jats:italic>\n                    intron 1 CGI region as an attractive therapeutics target for gene therapy in patients who suffer from synucleinopathies due to\n                    <jats:italic>SNCA<\/jats:italic>\n                    dysregulation.\n                  <\/jats:p>","DOI":"10.3389\/fnins.2021.652226","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:52:01Z","timestamp":1619571121000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Cell-Type Specific Changes in DNA Methylation of SNCA Intron 1 in Synucleinopathy Brains"],"prefix":"10.3389","volume":"15","author":[{"given":"Jeffrey","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Beach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy L.","family":"Woltjer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geidy E.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Kantor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornit","family":"Chiba-Falek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jns.2013.11.033","article-title":"Hypomethylation of SNCA in blood of patients with sporadic Parkinson\u2019s disease.","volume":"337","author":"Ai","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1093\/hmg\/ddu334","article-title":"Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.","volume":"23","author":"Bras","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.neurobiolaging.2013.11.031","article-title":"Global changes in DNA methylation and hydroxymethylation in Alzheimer\u2019s disease human brain.","volume":"35","author":"Coppieters","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2012-13-6-r43","article-title":"Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood.","volume":"13","author":"Davies","year":"2012","journal-title":"Genome Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"9031","DOI":"10.1074\/jbc.C110.212589","article-title":"Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases.","volume":"286","author":"Desplats","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/pcn.12462","article-title":"DNA methylation changes at SNCA intron 1 in patients with dementia with Lewy bodies.","volume":"71","author":"Funahashi","year":"2016","journal-title":"Psychiatry Clin. Neurosci."},{"key":"B7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneur.58.2.186","article-title":"Synucleinopathies: clinical and pathological implications.","volume":"58","author":"Galvin","year":"2001","journal-title":"Arch. Neurol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-017-0285-z","article-title":"Hypomethylation of intron1 of \u03b1-synuclein gene does not correlate with Parkinson\u2019s disease.","volume":"10","author":"Guhathakurta","year":"2017","journal-title":"Mol. Brain"},{"key":"B9","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1101\/gr.112755.110","article-title":"Neurons show distinctive DNA methylation profile and higher interindividual variations compared with non-neurons.","volume":"21","author":"Iwamoto","year":"2011","journal-title":"Genome Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1002\/mds.10557","article-title":"Neuropathological spectrum of synucleinopathies.","author":"Jellinger","year":"2003","journal-title":"Mov Disord."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-9-42","article-title":"Isolation of neuronal chromatin from brain tissue.","volume":"9","author":"Jiang","year":"2008","journal-title":"BMC Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","article-title":"Methylation regulates alpha-synuclein expression and is decreased in Parkinson\u2019s disease patients\u2019 brains.","volume":"30","author":"Jowaed","year":"2010","journal-title":"J. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.ymthe.2018.08.019","article-title":"Downregulation of SNCA expression by targeted editing of DNA methylation: a potential strategy for precision therapy in PD.","volume":"26","author":"Kantor","year":"2018","journal-title":"Mol. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/nar\/gkt838","article-title":"Differences in DNA methylation between human neuronal and glial cells are concentrated in enhancers and non-CpG sites.","volume":"42","author":"Kozlenkov","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/bs.pbr.2020.02.004","article-title":"The role of glia in Parkinson\u2019s disease: emerging concepts and therapeutic applications.","volume":"252","author":"Kuter","year":"2020","journal-title":"Prog. Brain Res."},{"key":"B16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jama.296.6.661","article-title":"Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.","volume":"296","author":"Maraganore","year":"2006","journal-title":"JAMA"},{"key":"B17","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1002\/mds.10559","article-title":"Clinical overview of the synucleinopathies.","author":"Marti","year":"2003","journal-title":"Mov. Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/0076-6879(90)81109-8","article-title":"Preparation of active nuclei.","volume":"181","author":"Marzluff","year":"1990","journal-title":"Methods Enzymol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015522","article-title":"CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson\u2019s disease.","volume":"5","author":"Matsumoto","year":"2010","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1212\/WNL.53.5.902","article-title":"Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies.","volume":"53","author":"McKeith","year":"1999","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/hmg\/ddl030","article-title":"Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson\u2019s disease.","volume":"15","author":"Mizuta","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"B23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.20438","article-title":"Multiple regions of alpha-synuclein are associated with Parkinson\u2019s disease.","volume":"57","author":"Mueller","year":"2005","journal-title":"Ann. Neurol."},{"key":"B24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1600-0404.2008.01019.x","article-title":"Multiple alpha-synuclein gene polymorphisms are associated with Parkinson\u2019s disease in a Norwegian population.","volume":"118","author":"Myhre","year":"2008","journal-title":"Acta Neurol. Scand."},{"key":"B25","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease.","volume":"46","author":"Nalls","year":"2014","journal-title":"Nat. Genet."},{"key":"B26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.20268","article-title":"alpha-Synuclein promoter confers susceptibility to Parkinson\u2019s disease.","volume":"56","author":"Pals","year":"2004","journal-title":"Ann. Neurol."},{"key":"B27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00439-008-0582-9","article-title":"Genomewide association study for susceptibility genes contributing to familial Parkinson disease.","volume":"124","author":"Pankratz","year":"2009","journal-title":"Hum. Genet."},{"key":"B28","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.mad.2007.04.002","article-title":"Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson\u2019s disease.","volume":"128","author":"Ross","year":"2007","journal-title":"Mech. Ageing Dev."},{"key":"B29","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ng.485","article-title":"Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson\u2019s disease.","volume":"41","author":"Satake","year":"2009","journal-title":"Nat. Genet."},{"key":"B30","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease.","volume":"41","author":"Simon-Sanchez","year":"2009","journal-title":"Nat. Genet."},{"key":"B31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1353-8020(99)00031-0","article-title":"Parkinson\u2019s disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies.","volume":"5","author":"Spillantini","year":"1999","journal-title":"Parkinsonism Relat. Disord."},{"key":"B32","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies.","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10048-016-0478-0","article-title":"Up-regulation of SNCA gene expression: implications to synucleinopathies.","volume":"17","author":"Tagliafierro","year":"2016","journal-title":"Neurogenetics"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0314-8","article-title":"Glial phagocytic clearance in Parkinson\u2019s disease.","volume":"14","author":"Tremblay","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"B35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/cns.12059","article-title":"A DNA methyltransferase inhibitor, 5-aza-2\u2019-deoxycytidine, exacerbates neurotoxicity and upregulates Parkinson\u2019s disease-related genes in dopaminergic neurons.","volume":"19","author":"Wang","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"B36","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1212\/01.wnl.0000275524.15125.f4","article-title":"{alpha}-Synuclein and Parkinson disease susceptibility.","volume":"69","author":"Winkler","year":"2007","journal-title":"Neurology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3233\/JAD-160430","article-title":"Elevated mRNA expression and low methylation of SNCA in Japanese Alzheimer\u2019s disease subjects.","volume":"54","author":"Yoshino","year":"2016","journal-title":"J. Alzheimers Dis."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2021.652226\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:52:16Z","timestamp":1619571136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2021.652226\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":37,"alternative-id":["10.3389\/fnins.2021.652226"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2021.652226","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]},"article-number":"652226"}}